OMDA· Health Care› Health Information Services

Omada Health, Inc.

Stage 3 · Topping · week 4

As of Oct 22, 2026, Omada Health is in Stage 3, the topping phase, now in week 4 (since Sep 28, 2026). It closed at $18.98, 29.1% below its 52-week high and above its 200-day average, which is rising.

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. More about the company

$18.98

-3.46% today

$1.2B · Small cap

Market Neutral — Building

Pro read

Pro

Our read

Topping: the uptrend is tiring

Setup score

—

Momentum

Steady

Edge

—

Is OMDA early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2025-06-06 → 2026-10-22

S? 42w

S1 9w

S2 12w

2025-06-062026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 42w → S4 5w → S1 9w → S2 12w → S3 4w current

Total tracked: 71 weeks across 5 stage runs.

OMDA among Health Information Services18th of 41 by relative strength

All 41 →

Stocks in Health Information Services ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	AMWLAmerican Well Corporation Class A	Stage 2 · wk 25	97	+7.4%
2	HNGEHinge Health, Inc. Class A	Stage 2 · wk 20	96	+19.1%
3	BTSGBrightSpring Health Services, Inc.	Stage 3 · wk 8	94	+9.1%
4	NRCNRC Health	Stage 3 · wk 4	93	−0.1%
5	SOPHSOPHiA GENETICS SA	Stage 2 · wk 24	91	−12.7%
6	HTFLHeartflow, Inc.	Stage 2 · wk 10	87	+17.0%
7	HSTMHealthStream, Inc.	Stage 2 · wk 17	77	+20.3%
8	OMCLOmnicell, Inc.	Stage 4 · wk 10	70	+12.5%
…18	OMDAOmada Health, Inc.	Stage 3 · wk 4	37	−8.3%

vs 52W High

-29.1%

$10.94 lo$26.78 hi

29.1% below 52W high, weakening from peak

The stock is rolling over from its 52-week high. In Stage 3 distribution, new long positions carry high risk.

Stage Maturity

Week 4

1w13w26w

Week 4, early distribution

How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.

vs 200 DMA

7.9%

200 DMA: $17.59 · rising

Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.

Rel Volume

0.54x

vs 50-day avg

Volume spikes on down days during Stage 3 signal distribution, with institutions exiting. Stage analysis reads that as a warning against new long positions.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-8.3%

-7.5%

+33.5%

YTD

+27.4%

-24.4%

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S3

Wk 4 · Vol 0.54x

2026-10-21S3

Wk 4 · Vol 0.83x

2026-10-20S3

Wk 4 · Vol 0.93x

2026-10-19S3

Wk 4 · Vol 0.53x

2026-10-16S3

Wk 3 · Vol 0.56x

2026-10-15S3

Wk 3 · Vol 1.13x

2026-10-14S3

Wk 3 · Vol 1.15x

2026-10-13S3

Wk 3 · Vol 2.05x

2026-10-12S3

Wk 3 · Vol 0.42x

2026-10-09S3

Wk 2 · Vol 0.59x

2026-10-08S3

Wk 2 · Vol 0.66x

2026-10-07S3

Wk 2 · Vol 0.88x

Moving averages & range

50 DMA

$21.34

200 DMA

$17.59

52W High

$26.78

52W Low

$10.94

5D Low

$17.63

Resistance levels (recent highs)

20d High

$21.87

60d High

$24.99

120d High

$24.99

250d High

$26.78

Next resistance

+15.2%

to 20d High

P/E (TTM)

79.1

Forward 34.1

ROE

+1.8%

Profit margin +1.4%

Dividend Yield

0.00%

P/B 4.6

Omada Health: quick answers

What stage is Omada Health in?

As of Oct 22, 2026, Omada Health (OMDA) is in Stage 3, the topping phase. It entered Stage 3 on Sep 28, 2026 and is in week 4. What the four stages mean

Is Omada Health in an uptrend?

Its uptrend has stalled. Omada Health is in Stage 3, the topping phase that follows an advance. It trades 7.9% above its 200-day average, which is rising.

How far is Omada Health from its 52-week high?

Omada Health closed at $18.98 on Oct 22, 2026, 29.1% below its 52-week high of $26.78. Its 52-week low is $10.94.

How has Omada Health performed over the past year?

As of Oct 22, 2026, Omada Health is down 24.4% over the past year and up 27.4% so far in 2026.

Which sector and industry is Omada Health in?

Omada Health is in the Health Information Services industry, part of the Health Care sector.

About this companyHealth Care· Health Information Services

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.